Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
0.5641
-0.0029 (-0.51%)
Apr 1, 2025, 10:48 AM EDT - Market open
Biomerica Market Cap
Biomerica has a market cap or net worth of $10.34 million as of April 1, 2025. Its market cap has decreased by -39.86% in one year.
Market Cap
10.34M
Enterprise Value
8.65M
1-Year Change
-39.86%
Ranking
Category
Stock Price
$0.56
Market Cap Chart
Since August 29, 2016, Biomerica's market cap has decreased from $24.30M to $10.34M, a decrease of -57.43%. That is a compound annual growth rate of -9.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 10.70M | 114.00% |
| Dec 31, 2024 | 5.00M | -76.19% |
| Dec 29, 2023 | 21.00M | -53.33% |
| Dec 30, 2022 | 45.00M | -7.60% |
| Dec 31, 2021 | 48.70M | -16.75% |
| Dec 31, 2020 | 58.50M | 96.97% |
| Dec 31, 2019 | 29.70M | 92.86% |
| Dec 31, 2018 | 15.40M | -51.72% |
| Dec 29, 2017 | 31.90M | 69.68% |
| Dec 30, 2016 | 18.80M | -22.63% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |